P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
Financial Results:
Procter & Gamble Health Ltd reported Revenues for Q4FY24 of ₹252.00 Crores down from ₹321.00 Crore year on year, a fall of 21.5%.
Total Expenses for Q4FY24 of ₹192.00 Crores down from ₹247.00 Crores year on year, a fall of 22.27%.
Consolidated Net Profit of ₹47.00 Crores down 20.34% from ₹59.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹28.05, down 21.34% from ₹35.66 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.